Sun Pharmaceutical Industries
May 25, 2012 at 11:46 | Source: Moneycontrol.com
May 25, 2012 at 09:17 | Source: Moneycontrol.com
May 25, 2012 at 08:19 | Source: Moneycontrol.com
May 24, 2012 at 12:46 | Source: Moneycontrol.com
May 18, 2012 at 12:58 | Source: Moneycontrol.com
May 16, 2012 at 15:28 | Source: Moneycontrol.com
News across the web »
May 25, 2012 at 06:42 | Source: Business Standard
May 25, 2012 at 02:06 | Source: Business Standard
May 24, 2012 at 14:00 | Source: NDTV Profit
May 19, 2012 at 02:01 | Source: Business Standard
May 16, 2012 at 19:41 | Source: DNA India
Interact & exchange stock tips & market info »
Related News »
Mumbai, May 24, 2012: Sun Pharmaceutical Industries Ltd. (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE: 524715) announced that the USFDA has granted its subsidiary an approval for its Abbreviated New Drug Application (ANDA ...
May 24, 2012 at 11:40 | Source: Phramalive.com
Mumbai: Drug maker Sun Pharmaceutical Industries Ltd’s Israeli subsidiary Taro Pharmaceutical Industries Ltd almost doubled its net profit to $47.3 million in the January-March quarter. The company had posted a net profit of $25.7 million in the year-ago period.
May 25, 2012 at 09:16 | Source: Livemint.com
Mumbai, May 18, 2012: Sun Pharmaceutical Industries Ltd. (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE: 524715) announced that the USFDA has granted its subsidiary an approval for its Abbreviated New Drug Application (ANDA ...
May 18, 2012 at 11:54 | Source: Phramalive.com
Sun Pharmaceutical Industries announced that it has bagged nod from the US health watchdog to market its generic edition of Astelin, utilized in addressing nasal allergies, in the US market. The pharma giant has got authorization from the USFDA for its ...
May 25, 2012 at 07:28 | Source: Top News India
The new fiscal year end was effectuated to align Taro's fiscal reporting period and its annual budget planning with that of its major shareholder, Sun Pharmaceutical Industries Ltd. ("Sun Pharma," Reuters: SUN.BO, Bloomberg: SUNP IN, NSE ...
May 24, 2012 at 20:22 | Source: Marketwatch
Sun Pharmaceutical Industries Limited's subsidiary has received approval from USFDA for its Abbreviated New Drug Application (ANDA) for its generic version of Astelin®, Azelastine HCL Nasal Spray, 0.1% (137 mcg/spray). This generic Azelastine ...
May 24, 2012 at 07:58 | Source: equitybulls.com
The press release "Taro Special Committee Continues to Evaluate Sun Pharma's Proposal to Acquire Taro Shares" was issued in error Friday by Business Wire. The press release and two headlines published at around 10:36 a.m. EDT have been removed from the ...
May 11, 2012 at 21:42 | Source: 4-traders (press release)
Sun Pharmaceutical Industries on Thursday said it had received approval from the US Food and Drug Administration to sell its generic version of Astelin, used in treating nasal allergies. The generic Azelastine HCL nasal spray, is therapeutically equivalent ...
May 19, 2012 at 12:50 | Source: Business Standard
New Delhi: Sun Pharmaceutical Industries today said it has received approval from the US health regulator to sell its generic version of Astelin, used in treating nasal allergies, in the American market. The company has received approval from ...
May 25, 2012 at 04:51 | Source: zeenews.india.com
Buy Sun Pharmaceutical Industries, Aurobindo Pharma, Lupin, Ranbaxy Laboratories & Divis Laboratories etc on dips. This sector was predicted last week also & on 16th May 2012, when nifty was down by over 100 points almost all prominent stocks from this ...
May 17, 2012 at 23:58 | Source: MoneyControl.com